| 1/31/2017 |
ZIOPHARM Utilizing Non-Viral Sleeping Beauty Platform to Rapidly Produce CAR-Expressing T cells Advancing "Point-of-Care" Approach |
| 1/26/2017 |
Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease |
| 1/24/2017 |
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform |
| 1/23/2017 |
|
| 1/19/2017 |
AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon |
| 1/12/2017 |
Intrexon Announces “When-Issued” Trading of AquaBounty Technologies In Connection With Special Stock Dividend of Shares |
| 1/10/2017 |
ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens |